广发港股创新药ETF联接(QDII)C(019671)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
656,249.07 |
1,894,277.67 |
377,256.62 |
9,627.37 |
| 存出保证金 |
241,530.62 |
656,201.82 |
53,081.66 |
15,428.96 |
| 交易性金融资产 |
3,046,218,531.53 |
3,290,462,935.45 |
845,497,705.03 |
109,185,717.05 |
| 其中:股票投资 |
- |
- |
- |
- |
| 债券投资 |
79,512,071.51 |
79,797,618.63 |
2,219,740.93 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
18,922,997.74 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
45,651,985.62 |
54,530,344.51 |
35,005,384.88 |
1,725,667.42 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
3,198,321,666.35 |
3,537,336,514.29 |
1,013,397,536.97 |
120,568,852.28 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
1,312,252.49 |
| 应付赎回款 |
110,895,009.71 |
161,666,957.81 |
115,715,268.23 |
2,266,880.65 |
| 应付管理人报酬 |
52,644.86 |
79,112.69 |
19,551.16 |
3,234.59 |
| 应付托管费 |
10,528.99 |
15,822.56 |
3,910.24 |
646.92 |
| 应付销售服务费 |
548,908.91 |
675,884.64 |
120,050.89 |
17,351.28 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
2,584.18 |
- |
57,287.37 |
19,053.65 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
102,835.73 |
195,675.98 |
87,946.13 |
135,041.50 |
| 负债合计 |
111,612,512.38 |
162,633,453.68 |
116,004,014.02 |
3,754,461.08 |
| 所有者权益 |
| 实收基金 |
2,752,878,595.78 |
2,685,296,118.30 |
751,268,420.58 |
147,914,168.86 |
| 未分配利润 |
333,830,558.19 |
689,406,942.31 |
146,125,102.37 |
-31,099,777.66 |
| 所有者权益合计 |
3,086,709,153.97 |
3,374,703,060.61 |
897,393,522.95 |
116,814,391.20 |
| 负债及所有者权益总计 |
3,198,321,666.35 |
3,537,336,514.29 |
1,013,397,536.97 |
120,568,852.28 |